Point72 Hong Kong LTD Ab Cellera Biologics Inc. Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $320,509 - $476,583
34,838 New
34,838 $345,000
Q4 2021

Feb 14, 2022
SELL
$12.99 - $17.73 $675 - $921
-52 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$23.29 - $53.2 $116,659 - $266,478
-5,009 Reduced 98.97%
52 $2,000
Q4 2020

Feb 16, 2021
BUY
$39.0 - $58.9 $197,379 - $298,092
5,061 New
5,061 $204,000

Others Institutions Holding ABCL

# of Institutions
155
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $807M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email